DNMT3A and hepatocellular carcinoma: Furthermore, miR-21 can regulate the expression of DNMT3A, and thereby control the activation of the promoter regions that promote hepatocellular carcinoma (HCC) cell growth and proliferation (Lin et al., 2023).